The costs and effectiveness of new anticancer drugs

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1055919

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

The general aim of this project is to assess new anticancer drugs and to determine what contributes to their cost, how well they work and their cost-effectiveness. Specific objectives include to systematically review recent evidence about the costs and cost-effectiveness of anticancer drugs, to perform cost-effectiveness analyses of expensive anticancer treatments based on data from clinical trials and to survey medical oncologists to determine their views on how treatment costs affect decision making.

Funded Activity Details

Start Date: 01-01-2013

End Date: 01-01-2015

Funding Scheme: Postgraduate Scholarships

Funding Amount: $89,699.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Oncology and Carcinogenesis not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

anticancer drug | colorectal cancer | decision making | economic analysis | gastric cancer | health economics | lung cancer | pancreatic cancer

Related Links